Catheter Precision Inc. (NYSE American: VTAK) Stock Surges Following LockeT Purchase Order from HCA Healthcare
Catheter Precision Inc. (NYSE American: VTAK) stands out as a key player in medical technology, renowned for its groundbreaking cardiac electrophysiology products, VIVO™ and LockeT. The rapid growth of the…